{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:15:01Z","timestamp":1788506101528,"version":"build-2803163510"},"reference-count":84,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Allergy"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atopic dermatitis (AD) is characterized by pruritus, epidermal hyperplasia, and lichenification that significantly impairs quality of life. Nemolizumab, an anti\u2013IL\u201031R\u03b1 monoclonal antibody, is approved for treating moderate\u2010to\u2010severe AD in patients aged &gt;\u200912\u2009years. This study investigated nemolizumab's molecular mechanisms using patient samples from the ARCADIA 1 (NCT03985943) and 2 (NCT03989349) trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Tape\u2010strips were collected from the lesional and non\u2010lesional skin of 71 nemolizumab\u2010treated and 39 placebo\u2010treated patients, all receiving background topical corticosteroids \u00b1 topical calcineurin inhibitors, at baseline and after 16\u2009weeks of treatment for bulk RNAseq analysis. Single cell RNAseq was performed on a subset of untreated patients and used as a reference to map bulk RNA\u2010seq DEGs, providing cellular context for treatment\u2010associated transcriptional changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Bulk RNAseq revealed significant transcriptomic modulation following 16\u2009weeks of nemolizumab treatment (797 downregulated\/142 upregulated genes), while placebo\u2010treated patients showed minimal changes. Nemolizumab treatment attenuated expression of pruritus\u2010related genes (e.g.,\n                      <jats:italic>OSMR<\/jats:italic>\n                      ,\n                      <jats:italic>TRPV3<\/jats:italic>\n                      ,\n                      <jats:italic>HRH1<\/jats:italic>\n                      ,\n                      <jats:italic>KLK6\/7\/9<\/jats:italic>\n                      ) and genes involved in epidermal hyperplasia and ECM remodeling (e.g.,\n                      <jats:italic>COL1A1\/12A1<\/jats:italic>\n                      ,\n                      <jats:italic>IGFBP3<\/jats:italic>\n                      ). Inflammatory pathways were also modulated, with downregulation of Th17\u2010 and Th1\u2010related genes (e.g.,\n                      <jats:italic>S100A7\/8\/9<\/jats:italic>\n                      ,\n                      <jats:italic>PI3<\/jats:italic>\n                      ,\n                      <jats:italic>MX1<\/jats:italic>\n                      ,\n                      <jats:italic>OASL<\/jats:italic>\n                      ). Pathway\u2010level analysis demonstrated normalization of pruritus and inflammatory gene signatures, including Th2 and Th22 pathways. Subgroup analysis showed that patients with severe baseline pruritus (PPNRS \u2265\u20097) had higher baseline expression of immune\u2010related genes and experienced greater downregulation following treatment compared to patients with moderate baseline itch. Single\u2010cell mapping of differentially expressed genes suggested enrichment of these genes in keratinocyte, fibroblast, endothelial, and nerve cell subpopulations. Clinically, improvements in EASI and pruritus scores (PPNRS) correlated with decreased expression of fibrosis\u2010 and pruritus\u2010associated genes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings provide molecular evidence supporting nemolizumab's therapeutic efficacy across multiple disease domains, including pruritus, inflammation, and epidermal hyperplasia, highlighting its role in AD treatment and management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/all.70505","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:09:47Z","timestamp":1788505787000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tape Strip Transcriptomics Reveal Nemolizumab Effects on Pruritus, Hyperplasia, Inflammation, and Extracellular Matrix Markers in Patients With Moderate\u2010to\u2010Severe Atopic Dermatitis"],"prefix":"10.1111","author":[{"given":"Daniel","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Dermatology Icahn School of Medicine at Mount Sinai  Mount Sinai New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7948-8536","authenticated-orcid":false,"given":"Ester Del","family":"Duca","sequence":"additional","affiliation":[{"name":"Department of Dermatology Icahn School of Medicine at Mount Sinai  Mount Sinai New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Delaleu","sequence":"additional","affiliation":[{"name":"Galderma  Lausanne Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Dermatology Icahn School of Medicine at Mount Sinai  Mount Sinai New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1014-3940","authenticated-orcid":false,"given":"Juliana","family":"Pulsinelli","sequence":"additional","affiliation":[{"name":"Department of Dermatology Icahn School of Medicine at Mount Sinai  Mount Sinai New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4221-1976","authenticated-orcid":false,"given":"Joel Correa","family":"de Rosa","sequence":"additional","affiliation":[{"name":"Department of Dermatology Icahn School of Medicine at Mount Sinai  Mount Sinai New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Bar","sequence":"additional","affiliation":[{"name":"Department of Dermatology Icahn School of Medicine at Mount Sinai  Mount Sinai New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeriel","family":"Estrada","sequence":"additional","affiliation":[{"name":"Department of Dermatology Icahn School of Medicine at Mount Sinai  Mount Sinai New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0080-0812","authenticated-orcid":false,"given":"Johann","family":"Gudjonsson","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Michigan  Ann Arbor Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Julia","sequence":"additional","affiliation":[{"name":"Galderma  Lausanne Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9363-324X","authenticated-orcid":false,"given":"Emma","family":"Guttman\u2010Yassky","sequence":"additional","affiliation":[{"name":"Department of Dermatology Icahn School of Medicine at Mount Sinai  Mount Sinai New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"issue":"2","key":"e_1_2_10_2_1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjd.19580","article-title":"The Global Burden of Atopic Dermatitis: Lessons From the Global Burden of Disease Study 1990\u20132017","volume":"184","author":"Laughter M. R.","year":"2021","journal-title":"British Journal of Dermatology"},{"issue":"10478","key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(24)02519-4","article-title":"Atopic Dermatitis","volume":"405","author":"Guttman\u2010Yassky E.","year":"2025","journal-title":"Lancet"},{"issue":"2","key":"e_1_2_10_4_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.sder.2011.05.002","article-title":"Management of Itch in Atopic Dermatitis","volume":"30","author":"Hong J.","year":"2011","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"issue":"3","key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.alit.2022.04.003","article-title":"Peripheral Itch Sensitization in Atopic Dermatitis","volume":"71","author":"Tominaga M.","year":"2022","journal-title":"Allergology International"},{"issue":"6","key":"e_1_2_10_6_1","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jaci.2009.09.031","article-title":"Broad Defects in Epidermal Cornification in Atopic Dermatitis Identified Through Genomic Analysis","volume":"124","author":"Guttman\u2010Yassky E.","year":"2009","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"e_1_2_10_7_1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaci.2021.01.001","article-title":"The Molecular Features of Normal and Atopic Dermatitis Skin in Infants, Children, Adolescents, and Adults","volume":"148","author":"Renert\u2010Yuval Y.","year":"2021","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"e_1_2_10_8_1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.anai.2018.11.015","article-title":"Racial Differences in Atopic Dermatitis","volume":"122","author":"Brunner P. M.","year":"2019","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"2","key":"e_1_2_10_9_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.anai.2023.11.020","article-title":"Diversity of Atopic Dermatitis and Selection of Immune Targets","volume":"132","author":"Rothenberg\u2010Lausell C.","year":"2024","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"10","key":"e_1_2_10_10_1","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.4049\/jimmunol.181.10.7420","article-title":"Low Expression of the IL\u201023\/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis","volume":"181","author":"Guttman\u2010Yassky E.","year":"2008","journal-title":"Journal of Immunology"},{"issue":"5","key":"e_1_2_10_11_1","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaci.2015.08.015","article-title":"The Asian Atopic Dermatitis Phenotype Combines Features of Atopic Dermatitis and Psoriasis With Increased TH17 Polarization","volume":"136","author":"Noda S.","year":"2015","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"e_1_2_10_12_1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2018.08.024","article-title":"Atopic Dermatitis in African American Patients Is TH2\/TH22\u2010Skewed With TH1\/TH17 Attenuation","volume":"122","author":"Sanyal R. D.","year":"2019","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"4","key":"e_1_2_10_13_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/exd.13514","article-title":"Atopic Dermatitis in Diverse Racial and Ethnic Groups\u2010Variations in Epidemiology, Genetics, Clinical Presentation and Treatment","volume":"27","author":"Kaufman B. P.","year":"2018","journal-title":"Experimental Dermatology"},{"issue":"55","key":"e_1_2_10_14_1","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe2749","article-title":"Persistence of Mature Dendritic Cells, T(H)2A, and Tc2 Cells Characterize Clinically Resolved Atopic Dermatitis Under IL\u20104R\u03b1 Blockade","volume":"6","author":"Bangert C.","year":"2021","journal-title":"Science Immunology"},{"issue":"5","key":"e_1_2_10_15_1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41423-023-00992-4","article-title":"The Translational Revolution in Atopic Dermatitis: The Paradigm Shift From Pathogenesis to Treatment","volume":"20","author":"Facheris P.","year":"2023","journal-title":"Cellular & Molecular Immunology"},{"issue":"5","key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cytogfr.2008.08.003","article-title":"Structures and Biological Functions of IL\u201031 and IL\u201031 Receptors","volume":"19","author":"Zhang Q.","year":"2008","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"3","key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jaci.2017.10.045","article-title":"IL\u201031: A New Key Player in Dermatology and Beyond","volume":"141","author":"Ba\u011fci I. S.","year":"2018","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"e_1_2_10_18_1","volume-title":"Galderma Receives U.S. FDA Approval for Nemluvio (Nemolizumab) for Patients With Moderate\u2010to\u2010Severe Atopic Dermatitis","author":"Galderma","year":"2024"},{"issue":"10451","key":"e_1_2_10_19_1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(24)01203-0","article-title":"Nemolizumab With Concomitant Topical Therapy in Adolescents and Adults With Moderate\u2010To\u2010Severe Atopic Dermatitis (ARCADIA 1 and ARCADIA 2): Results From Two Replicate, Double\u2010Blind, Randomised Controlled Phase 3 Trials","volume":"404","author":"Silverberg J. I.","year":"2024","journal-title":"Lancet"},{"key":"e_1_2_10_20_1","article-title":"Rapid Improvement of Itch With Nemolizumab in Atopic Dermatitis and Prurigo Nodularis Phase 3 Studies","volume":"45","author":"St\u00e4nder S.","year":"2025","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1","key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaci.2023.07.005","article-title":"Single\u2010Cell Profiling of Prurigo Nodularis Demonstrates Immune\u2010Stromal Crosstalk Driving Profibrotic Responses and Reversal With Nemolizumab","volume":"153","author":"Ma F.","year":"2024","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"e_1_2_10_22_1","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (From IL\u20101 to IL\u201038), Interferons, Transforming Growth Factor; and TNF: Receptors, Functions, and Roles in Diseases","volume":"138","author":"Akdis M.","year":"2016","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"e_1_2_10_23_1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01142","article-title":"T Cells in Fibrosis and Fibrotic Diseases","volume":"11","author":"Zhang M.","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"e_1_2_10_24_1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/sj.jid.5701149","article-title":"Gene Profiling of Keloid Fibroblasts Shows Altered Expression in Multiple Fibrosis\u2010Associated Pathways","volume":"128","author":"Smith J. C.","year":"2008","journal-title":"Journal of Investigative Dermatology"},{"issue":"6","key":"e_1_2_10_25_1","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1074\/jbc.M606262200","article-title":"Novel Genomic Effects of Glucocorticoids in Epidermal Keratinocytes: Inhibition of Apoptosis, Interferon\u2010Gamma Pathway, and Wound Healing Along With Promotion of Terminal Differentiation","volume":"282","author":"Stojadinovic O.","year":"2007","journal-title":"Journal of Biological Chemistry"},{"issue":"20","key":"e_1_2_10_26_1","doi-asserted-by":"crossref","first-page":"14063","DOI":"10.1074\/jbc.M707390200","article-title":"Ectopic SOX9 Mediates Extracellular Matrix Deposition Characteristic of Organ Fibrosis","volume":"283","author":"Hanley K. P.","year":"2008","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"e_1_2_10_27_1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2014.03.009","article-title":"Molecular Profiling of Contact Dermatitis Skin Identifies Allergen\u2010Dependent Differences in Immune Response","volume":"134","author":"Dhingra N.","year":"2014","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"11","key":"e_1_2_10_28_1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-2443.2005.00902.x","article-title":"Gene Expression in Human Keloids Is Altered From Dermal to Chondrocytic and Osteogenic Lineage","volume":"10","author":"Naitoh M.","year":"2005","journal-title":"Genes to Cells"},{"issue":"3","key":"e_1_2_10_29_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172955","article-title":"Site\u2010Specific Gene Expression Profiling as a Novel Strategy for Unravelling Keloid Disease Pathobiology","volume":"12","author":"Jumper N.","year":"2017","journal-title":"PLoS One"},{"key":"e_1_2_10_30_1","article-title":"RNA Sequencing Keloid Transcriptome Associates Keloids With Th2, Th1, Th17\/Th22, and JAK3\u2010Skewing","volume":"11","author":"Wu J.","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"e_1_2_10_31_1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jaci.2020.08.041","article-title":"Mild Atopic Dermatitis Lacks Systemic Inflammation and Shows Reduced Nonlesional Skin Abnormalities","volume":"147","author":"He H.","year":"2021","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"e_1_2_10_32_1","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jaci.2020.01.042","article-title":"Single\u2010Cell Transcriptome Analysis of Human Skin Identifies Novel Fibroblast Subpopulation and Enrichment of Immune Subsets in Atopic Dermatitis","volume":"145","author":"He H.","year":"2020","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"e_1_2_10_33_1","unstructured":"Consortium GO \u201cNeurogenesis \u201dGO: 0022008."},{"key":"e_1_2_10_34_1","unstructured":"Consortium GO \u201cNervous System Process \u201dGO: 0060384."},{"key":"e_1_2_10_35_1","unstructured":"Consortium GO \u201cPeripheral Nervous System Development \u201dGO: 0007422."},{"key":"e_1_2_10_36_1","unstructured":"Consortium GO \u201cEnsheathment of Neurons \u201dGO 0007272."},{"key":"e_1_2_10_37_1","unstructured":"Consortium GO \u201cNeuron Projection \u201dGO 0043005."},{"key":"e_1_2_10_38_1","unstructured":"Consortium GO \u201cGated Channel Activity \u201dGO 0022836."},{"issue":"619","key":"e_1_2_10_39_1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe3037","article-title":"Oncostatin M Can Sensitize Sensory Neurons in Inflammatory Pruritus","volume":"13","author":"Tseng P. Y.","year":"2021","journal-title":"Science Translational Medicine"},{"issue":"1","key":"e_1_2_10_40_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.jid.5700965","article-title":"Activation of Proteinase\u2010Activated Receptor\u20102 by Human Kallikrein\u2010Related Peptidases","volume":"128","author":"Stefansson K.","year":"2008","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"e_1_2_10_41_1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20082242","article-title":"Kallikrein 5 Induces Atopic Dermatitis\u2010Like Lesions Through PAR2\u2010Mediated Thymic Stromal Lymphopoietin Expression in Netherton Syndrome","volume":"206","author":"Briot A.","year":"2009","journal-title":"Journal of Experimental Medicine"},{"key":"e_1_2_10_42_1","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3397940","article-title":"SERPINB4 Promotes Keratinocyte Inflammation via p38MAPK Signaling Pathway","volume":"2023","author":"Zhang Y.","year":"2023","journal-title":"Journal of Immunology Research"},{"issue":"12","key":"e_1_2_10_43_1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126811","article-title":"Elevated Alpha 1(I) to Alpha 2(I) Collagen Ratio in Dermal Fibroblasts Possibly Contributes to Fibrosis in Systemic Sclerosis","volume":"23","author":"Sawamura S.","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"e_1_2_10_44_1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jid.2022.11.025","article-title":"CXCL9 Links Skin Inflammation and Fibrosis Through CXCR3\u2010Dependent Upregulation of Col1a1 in Fibroblasts","volume":"143","author":"Richmond J. M.","year":"2023","journal-title":"Journal of Investigative Dermatology"},{"issue":"10","key":"e_1_2_10_45_1","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1038\/jid.2012.164","article-title":"NF\u2010\u03baB Accumulation Associated With COL1A1 Transactivators Defects During Chronological Aging Represses Type I Collagen Expression Through a \u2010112\/\u201061\u2010Bp Region of the COL1A1 Promoter in Human Skin Fibroblasts","volume":"132","author":"Bigot N.","year":"2012","journal-title":"Journal of Investigative Dermatology"},{"issue":"4","key":"e_1_2_10_46_1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/DAD.0000000000000746","article-title":"Dermatofibrosarcoma Protuberans\u2010Like Tumor With COL1A1 Copy Number Gain in the Absence of t(17;22)","volume":"39","author":"Saab J.","year":"2017","journal-title":"American Journal of Dermatopathology"},{"issue":"3","key":"e_1_2_10_47_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/iovs.66.3.10","article-title":"Fibronectin Mediates Endothelial\u2010To\u2010Mesenchymal Transition in Retina Angiogenesis","volume":"66","author":"Liu D.","year":"2025","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"e_1_2_10_48_1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10456-008-9114-4","article-title":"The Discovery of the Placental Growth Factor and Its Role in Angiogenesis: A Historical Review","volume":"11","author":"Ribatti D.","year":"2008","journal-title":"Angiogenesis"},{"issue":"6","key":"e_1_2_10_49_1","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain\u2010Derived Neurotrophic Factor and Its Clinical Implications","volume":"11","author":"Bathina S.","year":"2015","journal-title":"Archives of Medical Science"},{"issue":"6","key":"e_1_2_10_50_1","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0002-9440(10)62493-5","article-title":"Microtubule\u2010Associated Protein 2, a Marker of Neuronal Differentiation, Induces Mitotic Defects, Inhibits Growth of Melanoma Cells, and Predicts Metastatic Potential of Cutaneous Melanoma","volume":"166","author":"Soltani M. H.","year":"2005","journal-title":"American Journal of Pathology"},{"key":"e_1_2_10_51_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fcell.2018.00005","article-title":"Central and Peripheral Nervous System Progenitors Derived From Human Pluripotent Stem Cells Reveal a Unique Temporal and Cell\u2010Type Specific Expression of PMCAs","volume":"6","author":"Chen M.","year":"2018","journal-title":"Frontiers in Cell and Development Biology"},{"issue":"8","key":"e_1_2_10_52_1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-018-0817-1","article-title":"Overexpression of PEAK1 Contributes to Epithelial\u2010Mesenchymal Transition and Tumor Metastasis in Lung Cancer Through Modulating ERK1\/2 and JAK2 Signaling","volume":"9","author":"Ding C.","year":"2018","journal-title":"Cell Death & Disease"},{"key":"e_1_2_10_53_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrep.2022.101358","article-title":"Potential Role of TGF\u0392 and Autophagy in Early Crebellum Development","volume":"32","author":"Dalvand A.","year":"2022","journal-title":"Biochemistry and Biophysics Reports"},{"issue":"6","key":"e_1_2_10_54_1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF\u2010\u03b2: The Master Regulator of Fibrosis","volume":"12","author":"Meng X.\u2010m.","year":"2016","journal-title":"Nature Reviews Nephrology"},{"issue":"3","key":"e_1_2_10_55_1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/stem.2231","article-title":"Transforming Growth Factor\u2010\u03b2\u2010Induced KDM4B Promotes Chondrogenic Differentiation of Human Mesenchymal Stem Cells","volume":"34","author":"Lee H. L.","year":"2016","journal-title":"Stem Cells"},{"key":"e_1_2_10_56_1","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.790129","article-title":"The Diverse Roles of Histone Demethylase KDM4B in Normal and Cancer Development and Progression","volume":"9","author":"Wang Z.","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"5","key":"e_1_2_10_57_1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/15592294.2018.1481703","article-title":"Inhibition of the Histone Demethylase KDM4B Leads to Activation of KDM1A, Attenuates Bacterial\u2010Induced Pro\u2010Inflammatory Cytokine Release, and Reduces Osteoclastogenesis","volume":"13","author":"Kirkpatrick J. E.","year":"2018","journal-title":"Epigenetics"},{"issue":"17","key":"e_1_2_10_58_1","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","article-title":"Phase 3 Trial of Nemolizumab in Patients With Prurigo Nodularis","volume":"389","author":"Kwatra S. G.","year":"2023","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_10_59_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbplus.2019.100019","article-title":"Kallikreins: Essential Epidermal Messengers for Regulation of the Skin Microenvironment During Homeostasis, Repair and Disease","volume":"6","author":"Nauroy P.","year":"2020","journal-title":"Matrix Biology Plus"},{"issue":"6","key":"e_1_2_10_60_1","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jid.2019.10.022","article-title":"Kallikrein 7 Promotes Atopic Dermatitis\u2010Associated Itch Independently of Skin Inflammation","volume":"140","author":"Guo C. J.","year":"2020","journal-title":"Journal of Investigative Dermatology"},{"key":"e_1_2_10_61_1","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.777619","article-title":"Human Tissue Kallikreins\u2010Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases","volume":"8","author":"Zani M. B.","year":"2021","journal-title":"Frontiers in Medicine (Lausanne)"},{"issue":"1","key":"e_1_2_10_62_1","doi-asserted-by":"crossref","first-page":"19723","DOI":"10.1038\/s41598-020-75683-5","article-title":"Red\u2010COLA1: A Human Fibroblast Reporter Cell Line for Type I Collagen Transcription","volume":"10","author":"Wong H. H.","year":"2020","journal-title":"Scientific Reports"},{"issue":"3","key":"e_1_2_10_63_1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/acn3.52225","article-title":"Clinical Characterization of Collagen XII\u2010Related Disease Caused by Biallelic COL12A1 Variants","volume":"12","author":"McCarty R. M.","year":"2025","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"2","key":"e_1_2_10_64_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0002-9440(10)62263-8","article-title":"Insulin\u2010Like Growth Factor Binding Proteins 3 and 5 Are Overexpressed in Idiopathic Pulmonary Fibrosis and Contribute to Extracellular Matrix Deposition","volume":"166","author":"Pilewski J. M.","year":"2005","journal-title":"American Journal of Pathology"},{"key":"e_1_2_10_65_1","volume-title":"Hyperkeratosis","author":"Mahabal F. F. G. D.","year":"2023"},{"issue":"5","key":"e_1_2_10_66_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100131","article-title":"Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis","volume":"2","author":"Beck L. A.","year":"2022","journal-title":"JID Innovation"},{"issue":"1","key":"e_1_2_10_67_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2021.11.006","article-title":"Skin Barrier Defects in Atopic Dermatitis: From Old Idea to New Opportunity","volume":"71","author":"Yoshida T.","year":"2022","journal-title":"Allergology International"},{"issue":"2","key":"e_1_2_10_68_1","doi-asserted-by":"crossref","first-page":"adv00024","DOI":"10.2340\/00015555-3344","article-title":"Mechanisms and Management of Itch in Dry Skin","volume":"100","author":"Moniaga C. S.","year":"2020","journal-title":"Acta Dermato\u2010Venereologica"},{"issue":"1","key":"e_1_2_10_69_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-018-0097-7","article-title":"Psychogenic Itch","volume":"8","author":"Misery L.","year":"2018","journal-title":"Translational Psychiatry"},{"issue":"1","key":"e_1_2_10_70_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111933","article-title":"Periostin Activates Distinct Modules of Inflammation and Itching Downstream of the Type 2 Inflammation Pathway","volume":"42","author":"Nunomura S.","year":"2023","journal-title":"Cell Reports"},{"issue":"4","key":"e_1_2_10_71_1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaci.2021.10.004","article-title":"Transcriptomic Characterization of Prurigo Nodularis and the Therapeutic Response to Nemolizumab","volume":"149","author":"Tsoi L. C.","year":"2022","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"e_1_2_10_72_1","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaci.2017.01.027","article-title":"Molecular Signatures Order the Potency of Topically Applied Anti\u2010Inflammatory Drugs in Patients With Atopic Dermatitis","volume":"140","author":"Guttman\u2010Yassky E.","year":"2017","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"e_1_2_10_73_1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/bjd\/ljaf275","article-title":"Tape Strips in Inflammatory Skin Disease: A Noninvasive Method for Molecular Insights and Personalized Care","volume":"193","author":"Liu D.","year":"2025","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"e_1_2_10_74_1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/all.15845","article-title":"Intrapatient Comparison of Atopic Dermatitis Skin Transcriptome Shows Differences Between Tape\u2010Strips and Biopsies","volume":"79","author":"Del Duca E.","year":"2024","journal-title":"Allergy"},{"issue":"11","key":"e_1_2_10_75_1","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.jid.2019.03.1160","article-title":"Side\u2010By\u2010Side Comparison of Skin Biopsies and Skin Tape Stripping Highlights Abnormal Stratum Corneum in Atopic Dermatitis","volume":"139","author":"Kim B. E.","year":"2019","journal-title":"Journal of Investigative Dermatology"},{"issue":"7","key":"e_1_2_10_76_1","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1172\/JCI58978","article-title":"Periostin Promotes Chronic Allergic Inflammation in Response to Th2 Cytokines","volume":"122","author":"Masuoka M.","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"e_1_2_10_77_1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2332\/allergolint.10-OA-0297","article-title":"Periostin Contributes to the Pathogenesis of Atopic Dermatitis by Inducing TSLP Production From Keratinocytes","volume":"61","author":"Shiraishi H.","year":"2012","journal-title":"Allergology International"},{"issue":"5","key":"e_1_2_10_78_1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.micinf.2009.04.001","article-title":"Differentiation and Function of Pro\u2010Inflammatory Th17 Cells","volume":"11","author":"Dong C.","year":"2009","journal-title":"Microbes and Infection"},{"issue":"11","key":"e_1_2_10_79_1","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/jid.2008.111","article-title":"Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis","volume":"128","author":"Koga C.","year":"2008","journal-title":"Journal of Investigative Dermatology"},{"issue":"3","key":"e_1_2_10_80_1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5114\/pdia.2013.35619","article-title":"Topical Calcineurin Inhibitors in Dermatology. Part I: Properties, Method and Effectiveness of Drug Use","volume":"30","author":"Gutfreund K.","year":"2013","journal-title":"Postepy Dermatologii I Alergologii"},{"issue":"3","key":"e_1_2_10_81_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/1346-8138.17877","article-title":"Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan","volume":"53","author":"Sasaki W.","year":"2026","journal-title":"Journal of Dermatology"},{"issue":"3","key":"e_1_2_10_82_1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.12788\/j.sder.2017.036","article-title":"Atopic Dermatitis: Pathogenesis","volume":"36","author":"Guttman\u2010Yassky E.","year":"2017","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"key":"e_1_2_10_83_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev-immunol-030409-101243","article-title":"Control of Immunity by the TNFR\u2010Related Molecule OX40 (CD134)","volume":"28","author":"Croft M.","year":"2010","journal-title":"Annual Review of Immunology"},{"issue":"4","key":"e_1_2_10_84_1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrrheum.2017.22","article-title":"Beyond TNF: TNF Superfamily Cytokines as Targets for the Treatment of Rheumatic Diseases","volume":"13","author":"Croft M.","year":"2017","journal-title":"Nature Reviews Rheumatology"},{"key":"e_1_2_10_85_1","first-page":"63","article-title":"OX40\u2010OX40 Ligand Interaction in T\u2010Cell\u2010Mediated Immunity and Immunopathology","volume":"105","author":"Ishii N.","year":"2010","journal-title":"Advances in Immunology"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/all.70505","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/all.70505","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/all.70505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:09:57Z","timestamp":1788505797000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/all.70505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":84,"alternative-id":["10.1111\/all.70505"],"URL":"https:\/\/doi.org\/10.1111\/all.70505","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"2026-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"all.70505"}}